西罗莫司洗脱支架和紫杉醇洗脱支架在常规临床实践中的五年结果：它们同样好（或差）吗？ - Suppr | 超能文献

Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?

作者信息

Cutlip Donald E

出版信息

Circulation. 2011 Jun 21;123(24):2779-81. doi: 10.1161/CIRCULATIONAHA.111.033654. Epub 2011 Jun 6.

DOI:10.1161/CIRCULATIONAHA.111.033654

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?西罗莫司洗脱支架和紫杉醇洗脱支架在常规临床实践中的五年结果：它们同样好（或差）吗？

Circulation. 2011 Jun 21;123(24):2779-81. doi: 10.1161/CIRCULATIONAHA.111.033654. Epub 2011 Jun 6.

2

Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.西罗莫司洗脱支架与紫杉醇洗脱支架随机比较的 5 年临床和血管造影结果：冠状动脉血运重建晚期紫杉醇洗脱支架与西罗莫司洗脱支架试验的结果。

Circulation. 2011 Jun 21;123(24):2819-28, 6 p following 2828. doi: 10.1161/CIRCULATIONAHA.110.004762. Epub 2011 Jun 6.

3

Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.西罗莫司洗脱支架与紫杉醇洗脱支架治疗慢性肾功能不全患者的比较。

J Interv Cardiol. 2010 Feb;23(1):33-9. doi: 10.1111/j.1540-8183.2009.00524.x.

4

Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.标签剥离凸显了药物洗脱支架非标签使用有益的越来越多的证据。

J Am Coll Cardiol. 2007 Nov 20;50(21):2037-8. doi: 10.1016/j.jacc.2007.08.020. Epub 2007 Nov 5.

5

Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.药物洗脱支架用于无保护左主干冠状动脉经皮介入治疗的两年（中期）结果

Indian Heart J. 2008 May-Jun;60(3):195-9.

6

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.对比两种药物洗脱冠状动脉支架在治疗双支病变患者中的效果：来自 SPIRIT III 随机试验的 2 年结果。

EuroIntervention. 2010 Sep;6(4):437-46. doi: 10.4244/EIJ30V6I4A75.

7

A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.糖尿病患者西罗莫司洗脱支架与紫杉醇洗脱支架植入的随机对照比较：DES-DIABETES试验的2年临床结果

J Am Coll Cardiol. 2009 Mar 3;53(9):812-3. doi: 10.1016/j.jacc.2008.11.028.

8

[Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].西罗莫司洗脱支架植入治疗紫杉醇洗脱支架再狭窄：血管造影及临床结果

Rev Esp Cardiol. 2008 Nov;61(11):1134-9.

9

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.用于无保护左主干冠状动脉疾病的紫杉醇洗脱支架与西罗莫司洗脱支架的比较

J Am Coll Cardiol. 2009 May 12;53(19):1760-8. doi: 10.1016/j.jacc.2009.01.035.

10

Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.糖尿病患者与非糖尿病患者中紫杉醇洗脱支架与西罗莫司洗脱支架的比较

Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):96-107. doi: 10.1161/CIRCOUTCOMES.108.826057. Epub 2009 Mar 5.